Regulation - Roche


Current filters:


Popular Filters

126 to 133 of 133 results

US FDA revokes Roche/Genentech Avastin license for metastatic breast cancer


After months of deliberations, the US Food and Drug Administration (FDA Commissioner is revoking the…

AvastinBiotechnologyGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

FDA priority review for Roche/Genentech’s vismodegib for skin cancer


The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

UK’s NICE provisionally backs wider use of Roche’s RoActemra for rheumatoid arthritis


The drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today opened…


Genentech files with US FDA for vismodegib in rare form of advanced skin cancer


In a second filing for a novel skin cancer drug this year, Swiss drug major Roche (ROG: SIX) US subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Two US FDA advisory panels say osteoporosis drugs need label changes


Experts advising the US Food and Drug Administration have recommended revised labeling for bisphosphonates,…

ActonelAnti-Arthritics/RheumaticsBonvivaFosamaxMerck & CoNorth AmericaPharmaceuticalReclastRegulationRocheWarner Chilcott

126 to 133 of 133 results

Back to top